| Q36153690 | 1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis |
| Q37666671 | 2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis |
| Q52684469 | A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome. |
| Q46350486 | A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis |
| Q37192486 | A novel mathematical model detecting early individual changes of insulin resistance |
| Q40117639 | Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. |
| Q35088381 | Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficien |
| Q46945532 | Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice. |
| Q35903298 | Animal models of atherosclerosis |
| Q26822630 | Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches |
| Q34355358 | Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes |
| Q35179999 | Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. |
| Q39028912 | Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis |
| Q40937316 | Association between HbA1c levels with severity of coronary artery disease and short-term outcomes of acute ST-elevation myocardial infarction in nondiabetic patients. |
| Q46974161 | Atherogenic vascular and lipid phenotypes in young patients with Type 1 diabetes are associated with diabetes high-risk HLA genotype |
| Q36857541 | Atherosclerosis in diabetes and insulin resistance |
| Q64271306 | Cardioprotective effects of a ruthenium (II) Schiff base complex in diet-induced prediabetic rats |
| Q64911301 | Cardiovascular Risk in Type 1 Diabetes Mellitus. |
| Q37172727 | Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies |
| Q48161819 | Characteristics of carotid atherosclerosis in elderly patients with type 2 diabetes at different disease course, and the intervention by statins in very elderly patients. |
| Q37011769 | Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations |
| Q36362707 | Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease |
| Q37333371 | Diabetes and atherosclerosis: is there a role for hyperglycemia? |
| Q35849515 | Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. |
| Q33901965 | Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys |
| Q53486855 | Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. |
| Q36658372 | Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation |
| Q36199128 | Diabetic vascular disease and the potential role of macrophage glucose metabolism |
| Q34399952 | Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin-treated, apolipoprotein E-deficient mice |
| Q42583454 | Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β-dependent vascular endothelial cadherin tyrosine phosphorylation |
| Q47103218 | Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β–dependent vascular endothelial cadherin tyrosine phosphorylation. |
| Q37083092 | Does Elevated Glucose Promote Atherosclerosis? Pros and Cons |
| Q46625417 | Dyslipidemias in type 1 diabetes: a current approach |
| Q35653968 | Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice |
| Q37526511 | Flow patterns regulate hyperglycemia-induced subendothelial matrix remodeling during early atherogenesis |
| Q42153827 | Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes |
| Q47116522 | High expression of long chain acyl-coenzyme A synthetase 1 in peripheral blood may be a molecular marker for assessing the risk of acute myocardial infarction |
| Q24530027 | Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice |
| Q90650768 | Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome |
| Q35830289 | Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes. |
| Q55355643 | Hyperglycemia does not affect tissue repair responses in shear stress-induced atherosclerotic plaques in ApoE-/- mice. |
| Q35013804 | Hyperglycemia impairs atherosclerosis regression in mice |
| Q64318898 | Hypolipidaemic Effects of High Resistant Starch Sago and Red Bean Flour- based Analog Rice on Diabetic Rats |
| Q37325024 | Immune and inflammatory mechanisms of atherosclerosis (*) |
| Q36701499 | Impact of diabetes on cardiovascular disease: an update |
| Q34459819 | Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury |
| Q37045424 | Increased antiangiogenic protein expression in the skeletal muscle of diabetic swine and patients |
| Q91795685 | Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes |
| Q38617809 | Increased serum levels of fetuin B in patients with coronary artery disease |
| Q38059912 | Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators. |
| Q46381890 | Inflammatory stimuli induce acyl-CoA thioesterase 7 and remodeling of phospholipids containing unsaturated long (≥C20)-acyl chains in macrophages. |
| Q64263678 | Influence of a Hyperglycemic Microenvironment on a Diabetic Versus Healthy Rat Vascular Endothelium Reveals Distinguishable Mechanistic and Phenotypic Responses |
| Q55280246 | Insulin resistance and coronary artery disease in non-diabetic patients: Is there any correlation? |
| Q27011696 | Insulin resistance, hyperglycemia, and atherosclerosis |
| Q38626570 | Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes |
| Q36082148 | Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications |
| Q41973235 | Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins? |
| Q26860086 | Lipids and the endothelium: bidirectional interactions |
| Q35140825 | Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes |
| Q34734402 | Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice. |
| Q57822566 | Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition |
| Q34336370 | Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury. |
| Q89967822 | Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes |
| Q36766171 | Mouse models for studies of cardiovascular complications of type 1 diabetes |
| Q36063184 | Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes |
| Q91586774 | Neurological Manifestation of Incretin-Based Therapies in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis |
| Q42180113 | Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes |
| Q37494520 | Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart. |
| Q37992593 | Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes |
| Q24676643 | Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis |
| Q83294236 | Preventing cardiovascular disease in type 2 diabetes: where do things stand with glycemic control? Part two |
| Q37108304 | Progression and disruption of advanced atherosclerotic plaques in murine models |
| Q42139014 | Regulation of plasma fructose and mortality in mice by the aldose reductase inhibitor lidorestat |
| Q35167826 | Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. |
| Q34559921 | Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice |
| Q36416215 | Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models? |
| Q34153709 | Role of diabetes, hypertension, and cigarette smoking on atherosclerosis |
| Q38213250 | Role of free radical in atherosclerosis, diabetes and dyslipidaemia: larger-than-life. |
| Q42717904 | Runx2 Deletion in Smooth muscle Cells Inhibits Vascular Osteochondrogenesis and Calcification but not Atherosclerotic Lesion Formation. |
| Q34769986 | S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation |
| Q52666460 | SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice. |
| Q39118050 | Sex Differences in Metabolic Cardiomyopathy |
| Q89013999 | Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome |
| Q89352761 | Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation |
| Q33612986 | Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis |
| Q37431941 | The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor |
| Q37380374 | The pathologic continuum of diabetic vascular disease |
| Q43609875 | The risk for coronary heart disease according to insulin resistance with and without type 2 diabetes |
| Q37464743 | Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials |
| Q36883079 | Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. |
| Q37195072 | Type 2 diabetes, mitochondrial biology and the heart |
| Q35881759 | Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture |
| Q33928035 | Uric acid levels are associated with microvascular endothelial dysfunction in patients with Type 1 diabetes |
| Q39951404 | Why does diabetes increase atherosclerosis? I don't know! |
| Q35023161 | n-3 Fatty Acids Decrease Arterial Low-Density Lipoprotein Cholesterol Delivery and Lipoprotein Lipase Levels in Insulin-Resistant Mice |